FM

Francois-Thomas Michaud

CEO

Feldan Therapeutics

Quebec City, Quebec


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Feldan Therapeutics
Industry
research
Employees
41.0
Seniority
C suite
Annual Revenue
3000000.0
Total Funding
54500000.0
Latest Funding
Series B

Technologies

Outlook Backbone JS Library Hubspot Mobile Friendly Facebook Widget Linkedin Login Facebook Login (Connect) Google Tag Manager Linkedin Widget Google Analytics

Keywords

genome modified cell therapies & shuttle technology disruptive platform for delivery of transcript biotechnology medical technologies therapeutics life sciences biotechnology research clinical-stage pharmaceutical company intracellular delivery feldan shuttle peptide-based technology non-invasive treatment fld-103 basal cell carcinoma biotherapeutics drug development cell-penetrating peptides antibody delivery gene editing therapeutic innovations patient quality of life pulmonary drug delivery skin disease treatments efficacy trials surgical alternatives transformative therapies research & development pharmaceutical licensing crucial partnerships biopharmaceutical pipeline safety assessments clinical trials oncology treatments biomedical engineering cellular therapies targeted therapy therapeutic compounds cellular biology drug discovery biochemical pathways disease intervention therapeutic enhancements biologics crispr technologies small molecule delivery treatment modalities molecular therapeutics drug efficacy healthcare advancements phase 1 trials patient-centric solutions clinical outcomes cellular mechanism of action drug formulation medical science advancements health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans